Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ACGN | Common Stock | Purchase | $38.3K | +27K | +18.76% | $1.42 | 171K | May 17, 2023 | By Abude Umari See Footnote | F1 |
holding | ACGN | Common Stock | 355K | May 17, 2023 | By Pillar Partners Foundation, L.P. See Footnote | F1 | |||||
holding | ACGN | Common Stock | 136K | May 17, 2023 | By Pillar Pharmaceuticals 6, L.P. See Footnote | F1 | |||||
holding | ACGN | Common Stock | 1.55K | May 17, 2023 | By Youssef El Zein See Footnote | F1 |
Id | Content |
---|---|
F1 | Pillar Invest Corporation ("Pillar GP") is the general partner of Pillar Pharmaceuticals 6, L.P. ("Pillar 6") and Pillar Partners Foundation, L.P. ("Pillar Partners", together with Pillar GP and Pillar 6, the "Pillar Funds"). Youssef El Zein and Abude Umari are directors of Pillar GP. Each of Pillar GP, Mr. El Zein and Mr. Umari disclaims Section 16 beneficial ownership of the securities beneficially owned by the Pillar Funds and this report shall not be deemed an admission that any of Pillar GP, Mr. El Zein or Mr. Umari is the Section 16 beneficial owner of any such securities, except to the extent of its or his pecuniary interest therein, if any, by virtue of its or his ownership interest in the Pillar Funds or Pillar GP, as applicable. |